Program Updates and Key Milestones Verona's near-term milestones include: Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre net sales of$71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 ® Q1 2025 revenue exceeds operating expenses excluding non-cash charges Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST LONDON and RALEIGH, N.C., April 29, 2025 – Verona Pharma plc (Nasdaq: ...